Aging
Navigate
Submit an Article
Research Paper|Volume 12, Issue 24|pp. 25767–25777
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells
Back to articleFigure 4(4 of 7)
100%
Figure 4
Figure 4.The ROS levels in the ZnO-NPs, Cp, Gem, Cp+Gem, ZnO-NPs(Cp), ZnO-NPs(Gem) and ZnO NPs(Cp/Gem) groups are tested by CellROX probe method.